Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy
1 other identifier
observational
300
1 country
1
Brief Summary
The goal of this observational study is to learn the patient journey, disease burden, living situation, quality of life and etc. in patients with Facioscapulohumeral Muscular Dystrophy in all sex/gender and age groups. The main questions it aims to answer are:
- 1.What's the patient journey of patients with Facioscapulohumeral Muscular Dystrophy?
- 2.How does Facioscapulohumeral Muscular Dystrophy burden the patients?
- 3.How's the quality of life of patients with Facioscapulohumeral Muscular Dystrophy?
- 4.fill a questionnaire.
- 5.be interviewed and answer questions about their illness experience, economic burden, quality of life and etc.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 9, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJuly 24, 2024
July 1, 2024
1 year
July 9, 2024
July 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
EQ-5D
EQ-5D questionnaires will be used to measure the quality of life of the patients. The questionnaires consist of two main parts: Descriptive System and Visual Analog Scale. Descriptive System includes Mobility, Self-Care, Usual Activities, Pain/Discomfort and Anxiety/Depression, each with 5 levels for adults and 3 levels for children. Visual Analog Scalerequires patients to rate their overall health on a scale from 0 to 100, where 0 represents "the worst health you can imagine" and 100 represents "the best health you can imagine." In the end, an index value will be calculated that reflects the patient's overall health status.
1 year
Anxiety Level
The Self-Rating Anxiety Scale will be used to measure the anxiety level of the patients. It consists of 20 items, each describing a common symptom of anxiety. Each item is rated on a 4-point Likert scale. The total score ranges from 20 to 80. In doing so, the anxiety level of the patients can be screened.
1 year
Economic Burden
Questions will designed to explore the economic burden of the patients. Questions include direct and indirect medical costs over the past year, annual incomes, accumulated treatment costs and debts. Each questions include 7 levels. Besides, whether they have public health insurance and commercial insurance will be asked to discover how much the costs can be covered.
1 year
Disease Burden
Questions will designed to explore the disease burden of the patients. Questions include the influence of the disease on respiratory system, dry eyes, whistle, deglutition, speaking and walking. Each question contains 5 levels.
1 year
Study Arms (1)
Patients With Facioscapulohumeral Muscular Dystrophy
No intervention will be administered
Interventions
No Intervention will be conducted
Eligibility Criteria
The study will focus on individuals diagnosed as Facioscapulohumeral Muscular Dystrophy in all sex and age groups.
You may qualify if:
- Having been diagnosed as Facioscapulohumeral Muscular Dystrophy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science Center of Xi'an Jiaotong University
Xi'an, Shaanxi, 710049, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenjing Ji, PhD
Xi'an Jiaotong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2024
First Posted
July 24, 2024
Study Start
March 1, 2024
Primary Completion
March 1, 2025
Study Completion
July 1, 2025
Last Updated
July 24, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared